SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): November
(Exact name of Registrant as Specified in its Charter)
(State Or Other Jurisdiction Of Incorporation)
|(Commission File Number)
||(I.R.S. Employer Identification No.)|
|14405 21st Avenue North
|(Address Of Principal Executive Offices)
Registrant’s Telephone Number, Including Area
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Items under Sections 2 through 8 are not applicable and are therefore omitted.
||ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT|
On November 30, 2012, Urologix, Inc. (the “Company”) entered
into a First Amendment to Loan and Security Agreement (the “Amendment”) with Silicon Valley Bank (“SVB”).
A copy of the Amendment is attached hereto as Exhibit 10.1. The Amendment modifies the original Loan and Security Agreement entered
into with SVB on January 11, 2012.
Under the Amendment, the Company must meet a financial covenant that requires
the Company’s maximum loss, on a trailing three month period, be not greater than $1.5 million, tested on the last day of
each month. The covenant is subject to change as of July 31, 2013 based on the Company’s Board-approved annual financial
projections for the June 30, 2014 year end.
This summary of the Amendment does not purport to be complete and is subject
to and qualified in its entirety by reference to the Amendment attached hereto as an exhibit.
||FINANCIAL STATEMENTS AND EXHIBITS|
||First Amendment to Loan and Security Agreement dated November 30, 2012 by and between Silicon Valley Bank and Urologix, Inc.|
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
||/s/ Brian J. Smrdel|
||Brian J. Smrdel|
Chief Financial Officer
Date: December 6, 2012